Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
Nabriva Therapeutics plc (NBRV)
Sector: Healthcare; Industry: Biotechnology

Nabriva Therapeutics plc, a biopharmaceutical company, engages in the research and development of anti-infective agents to treat infections in humans. Its lead product candidate is lefamulin, a semi-synthetic pleuromutilin antibiotic for the treatment of community-acquired bacterial pneumonia; and has completed Phase II clinical trials for the treatment of acute bacterial skin and skin structure infection. The company was formerly known as Nabriva Therapeutics Forschungs GmbH and changed its name to Nabriva Therapeutics plc in 2007. Nabriva Therapeutics plc was incorporated in 2005 and is headquartered in Dublin, Ireland.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2022-08-02 BURGESS DANIEL D Director Sell 11,341 $0.19 $2,156 No
2022-08-02 Broom Colin MD Director Sell 5,339 $0.19 $1,015 No
2022-08-02 Webster Stephen W Director Sell 7,826 $0.19 $1,487 No
2022-08-02 CORRIGAN MARK Director Sell 10,297 $0.19 $1,956 No
2022-08-01 Rowland Charles A Jr Director Sell 8,496 $0.17 $1,487 No
2021-12-28 Schroeder Theodore R Chief Executive Officer Buy 100,000 $0.57 $57,320 No
2021-12-27 Naftzger J. Christopher General Counsel and Corp Sec Buy 7,000 $0.59 $4,130 No
2021-09-14 Schroeder Theodore R Chief Executive Officer Buy 50,000 $1.13 $56,500 No
2021-08-02 Webster Stephen W Director Sell 777 $1.20 $932 No
2021-08-02 Broom Colin MD Director Sell 531 $1.20 $637 No
2020-08-20 Broom Colin MD Director Sell 11,064 $0.65 $7,165 Yes
2019-08-30 Broom Colin MD Director Buy 10,177 $2.03 $20,668 No
2019-08-27 Schroeder Theodore R Chief Executive Officer Buy 50,000 $1.79 $89,500 No
2019-08-22 Lavino Francesco Maria Chief Commercial Officer Buy 4,800 $2.04 $9,780 No
2019-08-21 Broom Colin MD Director Sell 10,177 $2.07 $21,066 No
2019-08-21 Gelone Steven P. President & COO Sell 8,206 $2.08 $17,068 No
2019-08-21 Crotty Robert Gen Counsel & Corp Secretary Sell 3,797 $2.08 $7,898 No
2019-08-21 Sender Gary Chief Financial Officer Sell 3,390 $2.08 $7,051 No
2019-08-21 Lavino Francesco Maria Chief Commercial Officer Sell 3,797 $2.08 $7,898 No
2018-12-24 Rowland Charles A Jr Director Buy 53,000 $1.31 $69,430 No
2018-07-31 Talbot George Harrison Director Buy 14,500 $2.75 $39,875 No
2018-07-31 BURGESS DANIEL D Director Buy 36,000 $2.75 $99,000 Yes
2018-06-23 Gelone Steven P. Chief Scientific Officer Buy 10,000 $3.82 $38,200 No
2018-06-22 Schranz Jennifer Chief Medical Officer Buy 5,500 $3.73 $20,515 No
2018-06-22 Broom Colin MD CEO & Director Buy 5,000 $3.72 $18,600 No
2018-05-23 Lavino Francesco Maria Chief Commercial Officer Buy 2,160 $4.60 $9,936 No
2018-05-23 Sender Gary Chief Financial Officer Buy 2,000 $4.57 $9,140 No
2018-05-23 Webster Stephen W Director Buy 8,000 $4.59 $36,720 No
2018-05-23 Broom Colin MD CEO & Director Buy 10,000 $4.60 $46,000 No
2018-05-23 Crotty Robert General Counsel & Secretary Buy 10,000 $4.48 $44,800 No

Insider Smart

ROYAL CARIBBEAN CRUISES (RCL) - Thompson Donald, Director of RCL feels safe and made a move. The only insiders bought RCL post crash.

Insider Smart

Liberty Media Corp (LSXMA) - BERKSHIRE HATHAWAY INC, Buffett made a move and add 2M shares to their position. What a news after dumping Airlines.